The average HbA1c reduction may have been attenuated by floor effect, as a high proportion of participants approached near-normal glycaemic levels
Mechanistically, these agents bind the GLP-1 receptor, enhancing glucose-dependent insulin secretion, slowing gastric emptying, and modulating appetite centers
Understanding Wegovy Side Effects Wegovy, known generically as Semaglutide, is a medication prescribed primarily for chronic weight management
For semaglutide specifically, the semaglutide reconstitution process and tirzepatide reconstitution process each have specific water-to-peptide ratios that affect both dosing accuracy and solution stability
What You Should Know About NAION Lawsuits Related to GLP-1 Use People taking glucagon-like peptide-1 (GLP-1) medications for diabetes or weight loss have experienced a significantly higher rate of the development of non-arteric ischemic optic neuropathy (NAION)